BACKGROUND: Activating transcription factor-2 (ATF2) is associated with tumor progression but is not well studied in head and neck squamous cell carcinoma (HNSCC). Its effects in stress and its importance in other survival mechanisms were studied. METHODS: ATF2 expression and nuclear activation were confirmed in HNSCC. After modulation of ATF2, in vitro effects on proliferation and chemosensitivity were studied. Effects on in vivo tumor growth and interleukin 8 (IL-8) expression were determined. Tumor necrosis factor-alpha (TNF-α) treatment was used to further evaluate cytokine production and chemosensitivity. RESULTS: Reductions of ATF2 resulted in significant nuclear p-ATF2 activation, cisplatin resistance, and augmented IL-8 expression without affecting in vivo tumor growth. In this setting, TNF increases p-p38 phosphorylation and chemosensitivity while further enhancing IL-8 production. CONCLUSION: Our data suggest regulatory roles for ATF2 in TNF-related mechanisms of HNSCC. Its perturbation and nuclear activation are associated with significant effects on survival and cytokine production.
BACKGROUND:Activating transcription factor-2 (ATF2) is associated with tumor progression but is not well studied in head and neck squamous cell carcinoma (HNSCC). Its effects in stress and its importance in other survival mechanisms were studied. METHODS:ATF2 expression and nuclear activation were confirmed in HNSCC. After modulation of ATF2, in vitro effects on proliferation and chemosensitivity were studied. Effects on in vivo tumor growth and interleukin 8 (IL-8) expression were determined. Tumor necrosis factor-alpha (TNF-α) treatment was used to further evaluate cytokine production and chemosensitivity. RESULTS: Reductions of ATF2 resulted in significant nuclear p-ATF2 activation, cisplatin resistance, and augmented IL-8 expression without affecting in vivo tumor growth. In this setting, TNF increases p-p38 phosphorylation and chemosensitivity while further enhancing IL-8 production. CONCLUSION: Our data suggest regulatory roles for ATF2 in TNF-related mechanisms of HNSCC. Its perturbation and nuclear activation are associated with significant effects on survival and cytokine production.
Authors: Wolfgang Breitwieser; Steve Lyons; Ann Marie Flenniken; Garry Ashton; Gail Bruder; Mark Willington; Georges Lacaud; Valerie Kouskoff; Nic Jones Journal: Genes Dev Date: 2007-08-15 Impact factor: 11.361
Authors: Catherine Wilson; Colin Purcell; Angela Seaton; Olabode Oladipo; Pamela J Maxwell; Joe M O'Sullivan; Richard H Wilson; Patrick G Johnston; David J J Waugh Journal: J Pharmacol Exp Ther Date: 2008-09-09 Impact factor: 4.030
Authors: Catherine Wilson; Timothy Wilson; Patrick G Johnston; Daniel B Longley; David J J Waugh Journal: Mol Cancer Ther Date: 2008-09 Impact factor: 6.261
Authors: Anindita Bhoumik; Boris Fichtman; Charles Derossi; Wolfgang Breitwieser; Harriet M Kluger; Sean Davis; Antonio Subtil; Paul Meltzer; Stan Krajewski; Nic Jones; Ze'ev Ronai Journal: Proc Natl Acad Sci U S A Date: 2008-01-28 Impact factor: 11.205
Authors: Joshua A Bauer; Bhavna Kumar; Kitrina G Cordell; Mark E Prince; Huong H Tran; Gregory T Wolf; Douglas B Chepeha; Theodoros N Teknos; Steven Wang; Avraham Eisbruch; Christina I Tsien; Susan G Urba; Francis P Worden; Julia Lee; Kent A Griffith; Jeremy M G Taylor; Nisha D'Silva; Shaomeng J Wang; Keith G Wolter; Bradley Henson; Susan G Fisher; Thomas E Carey; Carol R Bradford Journal: Int J Radiat Oncol Biol Phys Date: 2007 Impact factor: 7.038